Your browser doesn't support javascript.
loading
The beneficial effect over 3 years by pictorial information to patients and their physician about subclinical atherosclerosis and cardiovascular risk: Results from the VIPVIZA randomized clinical trial.
Bengtsson, Anna; Norberg, Margareta; Ng, Nawi; Carlberg, Bo; Grönlund, Christer; Hultdin, Johan; Lindahl, Bernt; Lindahl, Bertil; Nordin, Steven; Nyman, Emma; Wennberg, Patrik; Wester, Per; Näslund, Ulf.
Afiliação
  • Bengtsson A; Department of Public Health and Clinical Medicine, Umeå University, Umeå SE-901 87, Sweden.
  • Norberg M; Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
  • Ng N; Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
  • Carlberg B; Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden.
  • Grönlund C; School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Hultdin J; Department of Public Health and Clinical Medicine, Umeå University, Umeå SE-901 87, Sweden.
  • Lindahl B; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
  • Lindahl B; Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden.
  • Nordin S; Department of Public Health and Clinical Medicine, Umeå University, Umeå SE-901 87, Sweden.
  • Nyman E; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Wennberg P; Department of Psychology, Umeå University, Umeå, Sweden.
  • Wester P; Department of Public Health and Clinical Medicine, Umeå University, Umeå SE-901 87, Sweden.
  • Näslund U; Department of Public Health and Clinical Medicine, Umeå University, Umeå SE-901 87, Sweden.
Am J Prev Cardiol ; 7: 100199, 2021 Sep.
Article em En | MEDLINE | ID: mdl-34611639
ABSTRACT

OBJECTIVE:

Non-adherence to guidelines and preventive measures is a major challenge, particularly so to obtain long-term adherence to lifestyle changes and recommended medication. The objective was to investigate if pictorial information regarding subclinical carotid atherosclerosis provided to individuals and physicians gave sustained effects on cardiovascular risk beyond the previously reported effect after 1 year and up to 3 years.

METHODS:

A Prospective Randomized Open Blinded End-point (PROBE) trial. Within a CVD prevention program in Västerbotten County, Sweden, 3532 healthy individuals aged 40, 50 or 60 years were enrolled and 11 randomized to intervention (n = 1749; pictorial information with additional prevention materials to participants and physicians) or control group (n = 1783; no pictorial information to participants and physicians). Preventive measures were managed within primary care. Participants were investigated at baseline during 2013-2016 and at follow-up after 1 and 3 years.

RESULTS:

A beneficial effect on cardiovascular risk was observed at 3-year follow-up; Framingham Risk Score (FRS) was 13.38 for the intervention group and 14.08 for the control group (p = 0.047) and SCORE was 1.69 vs. 1.82 (p = 0.022). The effect observed at 1-year was sustained over 3 years after adjustment for sex and education and more pronounced among participants with a severe atherosclerotic picture at baseline.

CONCLUSIONS:

This study provides evidence of sustained beneficial effects on the adherence to prevention guidelines over 3 years of pictorial information about subclinical carotid atherosclerosis, resulting in lower cardiovascular risk regardless of sex and educational level. Direct visualization of the underlying still subclinical atherosclerotic disease, rather than just indirect information about risk factors and statistical risk of future myocardial infarction, stroke and death, is one way to tackle the problem of non-adherence to prevention of cardiovascular diseases.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Am J Prev Cardiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Revista: Am J Prev Cardiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia